Superior rejection profile during the first 24 months after heart transplantation under tacrolimus as baseline immunosuppressive regimen.

Drug Des Devel Ther · 2014 · PMC4166906 · PMID 25246772

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

All other considered risk factors did not reach statistical significance (all P = ns).

also in 111,027 other papers

showed a trendno p-value reported

Moreover, subgroup analysis showed a trend toward superiority of prolonged-release TAC.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.